Metagenomi Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $221.1M
Liabilities Breakdown FY2025
Total Liabilities: $62.5M
Asset Breakdown
Total Assets: $221.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $41.7M | 18.9% |
| Accounts Receivable | $305.0K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $12.3M | 5.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $166.8M | 75.4% |
Liabilities Breakdown
Total Liabilities: $62.5M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.5M | 2.4% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $61.0M | 97.6% |